Airlift bioreactors drive liquid circulation through gas buoyancy differences between the sparged riser (low density) and the unsparged downcomer (high density). This creates gentle, low-shear mixing without mechanical impellers — critical for fragile animal and plant cells whose membranes are damaged by high shear. They are used commercially for biopharmaceutical protein production from CHO, Vero, and hybridoma cells.